N Anthony Coles
CIK 1197018 · CEO and Chairperson · last filed 2026-01-06
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CERE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| REGN | Director | 1,714 | $816.10 | $1.40M | -$20.62M | 16 | 2026-01-06 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Director | 25,928 | $44.96 | $1.17M | -$30.40M | 22 | 2024-07-03 |
| KINETA, INC./DE (YMTX) Delisted | Executive Chair | 106,239 | $13.23 | $1.41M | $0 | 3 | 2021-04-02 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | President and CEO | — | $18.07 | — | $0 | 2 | 2021-02-05 |
| MCK | Director | 0 | $967.02 | $0 | -$558.3K | 9 | 2020-08-19 |
| CRISPR Therapeutics AG (PZRX) Delisted | Director | 70,000 | — | — | $0 | 3 | 2017-06-02 |
| ONYX PHARMACEUTICALS INC (ONXX) Delisted | Chairman & CEO | 131,198 | — | — | -$26.92M | 17 | 2013-06-07 |
| Campus Crest Communities, Inc. (RLD) Delisted | Director | 3,999 | — | — | $0 | 4 | 2013-05-31 |
| LH | Director | 3,008 | $331.17 | $996.2K | $0 | 4 | 2013-02-19 |
| NPS PHARMACEUTICALS INC (NPSP) Delisted | President, COO & Director | 147,638 | — | — | $0 | 7 | 2008-03-18 |
Recent Filings · Page 3 of 11
103 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-11-16 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$493.6K | EDGAR |
| 2023-11-09 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$585.0K | EDGAR |
| 2023-11-07 | — | Notice (144) | −50,000 | -$1.25M | EDGAR |
| 2023-11-06 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$2.18M | EDGAR |
| 2023-11-03 | — | Notice (144) | −50,000 | -$1.24M | EDGAR |
| 2023-11-02 | — | Notice (144) | −50,000 | -$1.27M | EDGAR |
| 2023-09-08 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$1.03M | EDGAR |
| 2023-09-07 | — | Notice (144) | −50,000 | -$1.21M | EDGAR |
| 2023-07-13 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$1.33M | EDGAR |
| 2023-07-11 | — | Notice (144) | −50,000 | -$1.53M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.